Somaiya Mayur Ian

Somaiya Mayur Ian is listed in filings as Chief Financial Officer at NewAmsterdam Pharma Company N.V.. This profile follows SEC Form 4 activity through Jan 22, 2026, including sale activity. Recent filings connect the profile to NewAmsterdam Pharma Company N.V. (NAMS). The current snapshot covers public activity from Jan 6, 2025 to Jan 22, 2026. Reported amounts are shown as $5.7M to $311.0K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.